Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.87B |
| 2 |
AABA
Altaba Inc
AABA
|
+$1.44B |
| 3 |
AGN
Allergan plc
AGN
|
+$547M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$525M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$510M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APC
Anadarko Petroleum
APC
|
+$688M |
| 2 |
WP
Worldpay, Inc.
WP
|
+$427M |
| 3 |
Blackstone
BX
|
+$416M |
| 4 |
RHT
Red Hat Inc
RHT
|
+$391M |
| 5 |
LLL
L3 Technologies, Inc.
LLL
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.44% |
| 2 | Financials | 10.55% |
| 3 | Healthcare | 8.78% |
| 4 | Consumer Discretionary | 7.66% |
| 5 | Industrials | 6.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
PUT
Comcast
CMCSA
$85B
| $16.7M | ﹤0.01% |
370,200
-393,100
| -52% | -$17.4M |
|
1927
Benchmark Electronics
BHE
$2.87B
| $16.7M | ﹤0.01% |
573,721
+430,752
| +301% | +$11.5M |
|
1928
Pacific Biosciences
PACB
$435M
| $16.6M | ﹤0.01% |
3,221,950
-2,075,410
| -39% | -$11.6M |
|
1929
PUT
CVS Health
CVS
$133B
| $16.6M | ﹤0.01% |
263,494
+239,500
| +998% | +$14.2M |
|
1930
PUT
IBM
IBM
$211B
| $16.6M | ﹤0.01% |
119,453
-274,889
| -70% | -$37.1M |
|
1931
Dillards
DDS
$9.19B
| $16.6M | ﹤0.01% |
250,768
-27,954
| -10% | -$1.79M |
|
1932
Glaukos
GKOS
$9.83B
| $16.6M | ﹤0.01% |
264,800
-69,334
| -21% | -$4.88M |
|
1933
Minerals Technologies
MTX
$2.36B
| $16.5M | ﹤0.01% |
311,521
+69,811
| +29% | +$3.58M |
|
1934
UFP Industries
UFPI
$4.9B
| $16.5M | ﹤0.01% |
414,204
+333,128
| +411% | +$13M |
|
1935
AXIS Capital
AXS
$7.68B
| $16.5M | ﹤0.01% |
246,688
-125,080
| -34% | -$7.9M |
|
1936
PUT
Broadcom
AVGO
$1.85T
| $16.5M | ﹤0.01% |
596,000
-81,000
| -12% | -$2.3M |
|
|
STR
1937
DELISTED
Sitio Royalties
STR
| $16.4M | ﹤0.01% |
714,652
-18,224
| -2% | -$507K |
|
1938
iShares US Financials ETF
IYF
$4.67B
| $16.4M | ﹤0.01% |
255,168
+7,326
| +3% | +$465K |
|
1939
Enanta Pharmaceuticals
ENTA
$366M
| $16.4M | ﹤0.01% |
273,324
+96,787
| +55% | +$7.19M |
|
1940
ANI Pharmaceuticals
ANIP
$1.8B
| $16.4M | ﹤0.01% |
225,153
+178,875
| +387% | +$13.4M |
|
1941
Monro
MNRO
$383M
| $16.4M | ﹤0.01% |
207,607
-182,542
| -47% | -$14.6M |
|
1942
Pitney Bowes
PBI
$2.4B
| $16.4M | ﹤0.01% |
3,588,550
-193,798
| -5% | -$777K |
|
1943
Belden
BDC
$4.85B
| $16.4M | ﹤0.01% |
307,425
+1,105
| +0.4% | +$55.4K |
|
1944
First Citizens BancShares
FCNCA
$24.9B
| $16.4M | ﹤0.01% |
34,703
+1,096
| +3% | +$499K |
|
1945
National Bank Holdings
NBHC
$1.92B
| $16.3M | ﹤0.01% |
478,132
+81,266
| +20% | +$2.82M |
|
|
MZTI
1946
The Marzetti Company
MZTI
$2.93B
| $16.3M | ﹤0.01% |
117,775
+55,890
| +90% | +$8.32M |
|
1947
Kratos Defense & Security Solutions
KTOS
$8.74B
| $16.3M | ﹤0.01% |
874,792
-67,630
| -7% | -$1.42M |
|
|
1948
CALL
Broadcom
AVGO
$1.85T
| $16.3M | ﹤0.01% |
589,000
+83,000
| +16% | +$2.36M |
|
1949
Vanguard Total International Bond ETF
BNDX
$81.9B
| $16.2M | ﹤0.01% |
275,932
-120,651
| -30% | -$7.04M |
|
1950
Sunrun
RUN
$2.34B
| $16.2M | ﹤0.01% |
971,087
+95,711
| +11% | +$1.67M |
|
Similar funds
Goldman Sachs's Q3 2019 Portfolio in Review
As of Q3 2019, Goldman Sachs held 5,584 positions worth $346B, down 0.39% from $347B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Goldman Sachs's Q3 2019 filing shows 478 new, 2,283 increased, 2,044 reduced and 441 closed positions. Its largest new stake was ProSight Global, Inc.: 17,005,092 shares worth $329M. The largest sale was Anadarko Petroleum, an estimated $688M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- Goldman Sachs's largest Q3 2019 buy was ProSight Global, Inc.: 17,005,092 shares worth $329M.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q3 2019, an estimated $1.87B increase.
- Goldman Sachs's biggest Q3 2019 reduction was Blackstone, cutting an estimated $416M.
- Goldman Sachs fully exited Anadarko Petroleum in Q3 2019, selling an estimated $688M.
- Goldman Sachs's ten largest holdings make up 14% of its $346B portfolio in Q3 2019.
- Goldman Sachs opened 478 new positions and closed 441 in Q3 2019.
- Goldman Sachs's portfolio value fell 0.39% quarter-over-quarter to $346B.
Based on Goldman Sachs's 13F filing for Q3 2019, filed 14 Nov 2019.